See more : AfterNext HealthTech Acquisition Corp. (AFTR-WT) Income Statement Analysis – Financial Results
Complete financial analysis of NatureCell Co.,Ltd. (007390.KQ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of NatureCell Co.,Ltd., a leading company in the Beverages – Non-Alcoholic industry within the Consumer Defensive sector.
- Villeroy & Boch AG (0OPA.L) Income Statement Analysis – Financial Results
- Founder Technology Group Co.,Ltd. (600601.SS) Income Statement Analysis – Financial Results
- NevGold Corp. (NAU.V) Income Statement Analysis – Financial Results
- Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ.DE) Income Statement Analysis – Financial Results
- Wolters Kluwer N.V. (WKL.AS) Income Statement Analysis – Financial Results
NatureCell Co.,Ltd. (007390.KQ)
About NatureCell Co.,Ltd.
NatureCell Co.,Ltd. manufactures and sells canned and health functional food products, beverages, stem cell, and cosmetics in South Korea and internationally. The company's products comprise fruit drinks, aloe vera drinks, coffee, energy drinks, and Korean sauces, as well as offers domestic products and ETC products under the SAMMI and OEM brands. It also provides services for the preservation of blood cells, such as endothelial progenitor cells, mononuclear cells, and platelet rich plasma products. The company was formerly known as RNL Sammi CO., Ltd. and changed its name to NatureCell Co.,Ltd. in April 2013. NatureCell Co.,Ltd. was founded in 1960 and is based in Seoul, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2012 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 19.35B | 21.25B | 20.35B | 16.72B | 23.07B | 26.72B | 27.22B | 26.79B | 27.21B |
| Cost of Revenue | 12.30B | 12.84B | 12.31B | 9.91B | 10.70B | 15.82B | 19.66B | 22.86B | 24.56B |
| Gross Profit | 7.05B | 8.41B | 8.04B | 6.81B | 12.37B | 10.90B | 7.56B | 3.93B | 2.65B |
| Gross Profit Ratio | 36.45% | 39.59% | 39.52% | 40.72% | 53.61% | 40.79% | 27.77% | 14.67% | 9.74% |
| Research & Development | 2.22B | 1.58B | 1.47B | 1.69B | 1.84B | 1.52B | 1.97B | 30.93M | 0.00 |
| General & Administrative | 731.31M | 598.10M | 639.07M | 408.91M | 0.00 | 0.00 | 0.00 | 0.00 | 61.71M |
| Selling & Marketing | 8.09B | 10.00B | 9.84B | 5.64B | 0.00 | 0.00 | 0.00 | 0.00 | 1.38B |
| SG&A | 15.05B | 15.73B | 15.02B | 12.83B | 8.77B | 8.49B | 6.20B | 7.53B | 3.05B |
| Other Expenses | 0.00 | -117.23M | -40.30M | -171.08M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 18.47B | 17.43B | 16.54B | 14.52B | 10.61B | 10.01B | 8.16B | 7.56B | 4.60B |
| Cost & Expenses | 29.63B | 30.27B | 28.85B | 24.43B | 21.31B | 25.83B | 27.82B | 30.42B | 29.16B |
| Interest Income | 731.57M | 343.37M | 92.11M | 260.75M | 153.58M | 158.72M | 333.93M | 500.64M | 12.41M |
| Interest Expense | 1.15B | 1.72B | 750.69M | 488.46M | 212.13M | 157.41M | 649.88M | 458.77M | 682.91M |
| Depreciation & Amortization | 1.75B | 911.19M | 1.59B | 1.56B | 1.39B | 922.93M | 849.05M | 557.46M | 292.48M |
| EBITDA | -8.67B | -5.36B | -27.31B | -15.19B | 2.66B | 3.32B | 236.02M | -3.70B | -967.37M |
| EBITDA Ratio | -44.82% | -38.14% | -33.90% | -36.77% | 13.66% | 6.77% | 0.89% | -11.47% | -0.61% |
| Operating Income | -10.27B | -9.02B | -8.49B | -7.71B | 1.76B | 886.68M | -607.75M | -3.63B | -457.26M |
| Operating Income Ratio | -53.09% | -42.42% | -41.72% | -46.10% | 7.63% | 3.32% | -2.23% | -13.55% | -1.68% |
| Total Other Income/Expenses | -1.30B | -1.29B | -22.17B | -9.53B | -703.33M | 1.35B | 147.01M | -1.05B | -1.49B |
| Income Before Tax | -11.57B | -7.21B | -29.65B | -17.24B | 1.06B | 2.23B | -460.74M | -3.61B | -1.94B |
| Income Before Tax Ratio | -59.79% | -33.93% | -145.69% | -103.09% | 4.58% | 8.37% | -1.69% | -13.48% | -7.14% |
| Income Tax Expense | -132.64M | 2.46B | 2.38B | 1.63B | 155.23M | -2.00 | 3.00 | -387.15M | 43.83M |
| Net Income | -11.68B | -10.26B | -32.03B | -18.87B | 902.01M | 2.23B | -460.74M | -3.22B | -1.90B |
| Net Income Ratio | -60.36% | -48.29% | -157.37% | -112.86% | 3.91% | 8.37% | -1.69% | -12.03% | -6.98% |
| EPS | -183.80 | -163.86 | -518.71 | -308.38 | 16.23 | 39.40 | -8.39 | -60.07 | -75.00 |
| EPS Diluted | -183.80 | -163.86 | -518.71 | -308.38 | 16.23 | 39.40 | -8.39 | -60.07 | -75.00 |
| Weighted Avg Shares Out | 63.55M | 62.64M | 61.75M | 61.19M | 55.57M | 56.72M | 54.89M | 53.66M | 25.32M |
| Weighted Avg Shares Out (Dil) | 63.55M | 62.64M | 61.75M | 61.19M | 55.57M | 56.72M | 54.89M | 53.66M | 25.32M |
Source: https://incomestatements.info
Category: Stock Reports